KDM5B and hepatocellular carcinoma: PD-L1 antibody pulldown or KDM5B deficiency raised CD8+ T cell percentage and IFN-γ release in the coculture of PBMCs and HCC cells, with a greater effect observed with PD-L1 antibody pulldown combined with KDM5B silencing (supplementary Fig. 3C, D).